ots Ad hoc-Service: MediGene AG <DE0005020903> ACQUISITION OF NEUROVIR THERAPEUTICS, INC. BY MEDIGENE AG: INFORMATION MEMORANDUM DISTRIBUTED
Munich (ots Ad hoc-Service) -
Ad hoc-announcement edited and sent by DGAP. The sender is solely responsible for the contents of this announcement.
The closing of the acquisition of the biopharmaceutical company NeuroVir Therapeutics, Inc. (San Diego, CA) by MediGene AG (Munich, Germany, NMarkt: MDG) is almost completed. The last major step is the consent of NeuroVir shareholders' to the merger agreement which was signed by both companies in November 2000. The respective shareholders' meeting is scheduled for January 2001. Today, MediGene announced the distribution of an information memorandum to NeuroVir shareholders in compliance with U.S. and Canadian securities laws. The information memorandum contains, among other things, consolidated pro forma financial statements for the companies. To better conform to U.S. and Canadian accounting practices, the presentation of the cash flow statement in the information memorandum was modified, MediGene wants to provide all its existing and potential shareholders with the same updated information. Therefore, the information memorandum has been placed for downloading on MediGene's website (http://www.medigene.de). MediGene also will provide a copy of the information memorandum upon request (Contact: Mr. Michael Nettersheim, Investor Relations Manager).
For further information please contact:
MediGene AG email: investor@medigene.de fax: ++49-89-89 56 32-20
Christine Bohner, Public Relations phone: ++49-89-89 56 32-16 Michael Nettersheim, Investor Relations phone: ++49-89-89 56 32-46
End Internet: http://recherche.newsaktuell.de
Original content of: Medigene AG, transmitted by news aktuell